3 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 2 Not applicable, 1 Early Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Cefaclor: new trials by email Literature Review of Cefaclor trials Research Report on Cefaclor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-09-04 |
| Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem, Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor - Biliary Atresia, Cholangitis | Not applicable | Recruiting | Children's Hospital of Fudan University | 356 | 2023-07-01 | 2026-05-15 |
| Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection - Endocarditis Infective | Phase 4 | Recruiting | Fundacion Clinic per a la Recerca Biomédica | 360 | 2022-08-17 | 2026-07-07 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use Antibiotic - Snoring, Strep Throat | Not applicable | Completed | University of Missouri-Columbia | 58 | 2012-03-01 | 2017-01-19 |
| German Corneal Cross Linking Register CCL (Corneal Cross Linking) - Keratoconus | Active not recruiting | Suphi Taneri | 356 | 2007-11-01 | 2026-06-18 |
Anaphylaxis (1) · Biliary Atresia (1) · Cholangitis (1) · Corneal Diseases (1) · Drug Hypersensitivity (1) · Endocarditis (1) · Hypersensitivity (1) · Keratoconus (1) · Osteomyelitis (1) · Snoring (1)
Children's Hospital of Fudan University (1) · Fundacion Clinic per a la Recerca Biomédica (1) · Julio Ramirez (1) · Massachusetts General Hospital (1) · Suphi Taneri (1) · University of Missouri-Columbia (1)
United States (3) · China (1) · Germany (1) · Spain (1)
Arnd Heiligenhaus, MD (1) · Atilla Osvald, MD (1) · Berthold Seitz, MD (1) · Claus Cursiefen, MD (1) · David A Khan, MD (1) · David Seligson, MD (1) · Eliav Gov-Arie, MD (1) · Jan M Vetter, MD (1) · Julio Ramirez, MD (1) · Kimberly G Blumenthal, MD, MSc (1) · Philip Maier, MD (1) · Suphi Taneri, MD (1) · Theo Seiler, MD (1) · Thomas Reinhard, MD (1) · Walter Sekundo, MD (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 40024946, PMID 4902833, PMID 8948280
U01AI184071 (1)